BOZ ER, A. B. Et Al. 2024. Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy. International Journal of Molecular Sciences , vol.25, no.14 .

BOZ ER, A. B., Sheldrake, H. M., & Sutherland, M., (2024). Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy. International Journal of Molecular Sciences , vol.25, no.14.

BOZ ER, ASİYE, Helen M. Sheldrake, And Mark Sutherland. "Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy," International Journal of Molecular Sciences , vol.25, no.14, 2024

BOZ ER, ASİYE B. Et Al. "Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy." International Journal of Molecular Sciences , vol.25, no.14, 2024

BOZ ER, A. B. Sheldrake, H. M. And Sutherland, M. (2024) . "Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy." International Journal of Molecular Sciences , vol.25, no.14.

@article{article, author={ASİYE BÜŞRA BOZ ER Et Al. }, title={Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy}, journal={International Journal of Molecular Sciences}, year=2024}